(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 500mg

4,4'-Dimethylbenzhydrol, 98.0%, 25g

3-Bromo-2-methoxybenzonitrile, 95.0%, 25g

2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-[4-(1-methylpropyl)phenyl]acetamide, 98%, 100mg

Phenyl 2-(benzyloxy)-3-(dibenzylamino)-5-fluoro-6-methylbenzoate, 97%, 250mg

Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, 98%, 100mg

2-Ethoxypyridin-4-amine, 97.0%, 100g

2,3-Dichloro-6-methyl-5-(trifluoromethyl)aniline, 97.0%, 5g

1-Benzyl-4-(hydroxymethyl)piperidin-4-ol, 97.0%, 250mg

Sodium hydroxide solution 40%, extra pure, 10 l, plastic packaging.

N-desmethyl Enzalutamide, 100mg

2,6-Dibromobenzothiazole, 95.0%, 1g

His-Val-OH, 98.0%, 1g